GeneralConnection.com ➔ Dictionary
Dictionary Search

actinium

Synonyms

Noun

1. Ac

2. atomic number 89, chemical element, element

Usage
Scientists Develop Inorganic Resins for Generating and Purifying Radium and Actinium - Department of Energy (.gov)
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates - PR Newswire
Promising Phase 1 Data for Actinium-225 Presented at 2026 ASCO GU - Targeted Oncology
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand - BioSpace
Laser spectroscopy and CP-violation sensitivity of actinium monofluoride - Nature
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting - Yahoo Finance
Phase I PAnTHA Study Evaluates PSMA-Targeted Actinium-225 in mCRPC Patients - Fred Saad - UroToday
Cancer-drug developer Actinium gets NYSE notice with equity at $2.3M - Stock Titan
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - PR Newswire
Actinium-225 Demonstrates Safety and Responses in mCRPC - Targeted Oncology
Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - Yahoo Finance
Actinium Presents New ATNM-400 Data in KRAS and EGFR Mutant Models at SNMMI 2026 Supporting a Mutation-Agnostic Opportunity In Non-Small Cell Lung Cancer - PR Newswire
Exploring the Role of Actinium-225 in Metastatic Castration-Resistant Prostate Cancer - Targeted Oncology
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - PR Newswire
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization - PR Newswire
Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting - PR Newswire
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting - PR Newswire
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies - PR Newswire
Actinium Pharmaceuticals to Unveil the Multi-Tumor Potential of ATNM-400, a First-in-Class Actinium-225 Radiotherapy, with Data in Non-Small Cell Lung Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeut - PR Newswire
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC - BioWorld News
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposiu - PR Newswire
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation Scientific Retreat - PR Newswire
NorthStar and QSA Global Announce Multi-Year Strategic Partnership to Strengthen Actinium-225 Supply Chain for Targeted Alpha Therapies - PR Newswire
Male contraception startup closes $92.5M Series B; Novartis bets on actinium in Phase 3 - Endpoints News
Niowave kicks off construction of $75M radiopharmaceutical isotope plant in Michigan - Fierce Pharma
Actinium Announces Superior Anti-Tumor Activity of ATNM-400 in Lung Cancer Compared to the Leading First, Second and Third-Line Approved EGFR Mutant Therapies and Mechanistic Synergy with Osimertinib at the AACR-NCI-EORTC International Confer - PR Newswire
NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain - Manufacturing Chemist
Actinium Pharmaceuticals, Inc. to Highlight ATNM-400 Data in Hormone-Resistant and HER2-Resistant Breast Cancer at the 2025 San Antonio Breast Cancer Symposium, Expanding Pan-Tumor Profile Across Three Solid Tumor Indications - PR Newswire
TerraPower Commits $450M To Build Radioisotope Production Plant - BioSpace
Actinium Pharmaceuticals (NYSE: ATNM) faces NYSE American equity shortfall and listing risk - Stock Titan
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies - PR Newswire
Cardinal Health, Shine Technologies amp up domestic production of radio-pharmaceuticals - Cardinal Health
Pennsylvania to house new actinium-225 manufacturing facility - European Pharmaceutical Review
Actinium Recruits Oncology Veteran Steffen Heeger as CMO to Advance Radiotherapy Pipeline - citybiz
TerraPower Isotopes Invests $450M in Actinium-225 Production Facility - Oncodaily
UCLA Health launches novel clinical trial for recurrent prostate cancer - UCLA Health
The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals' (ATNM) Big Bet - TMX Newsfile
Actinium presents radiochemistry data on antibody ratio optimization - Investing.com
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225 - BioSpace
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - Yahoo Finance
Novartis advances actinium-based cancer drug after promising trial data - Mugglehead Investment Magazine
Niowave breaks ground on $75 million facility to expand Actinium-225 production - DOTmed
AstraZeneca locks in long-term actinium-225 supply with Niowave - The Pharma Letter
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La - Nature
TerraPower Isotopes, PanTera expand partnership to increase actinium-225 production - DOTmed
Actinium presents preclinical data on ATNM-400 for lung cancer - Investing.com
Actinium Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies - PR Newswire
Niowave Extends Actinium 225 Supply Agreement With AstraZeneca To Support Next Generation Cancer Therapies - BioPharma APAC
Actinium brings lung and prostate cancer data for ATNM-400 to SNMMI - Stock Titan
SK biopharmaceuticals secures European supply of actinium-225 through deal with Germany's Eckert & Ziegler - koreabiomed.com
Expanded Actinium‑225 Capacity And Higher EPS Guidance Could Be A Game Changer For Cardinal Health (CAH) - Yahoo Finance
Novartis taps Niowave for long-term supply of radiopharmaceutical isotope - Fierce Pharma
Jeri Kim: Thrilled to Join Actinium Pharmaceuticals as VP, Head of Solid Tumor Clinical Development - Oncodaily
SK Biopharmaceuticals Advances Actinium-Based RPT Cancer Drug Into Clinical Trials - thelec.net
Why Is Actinium Pharmaceuticals Stock Rising Today? - Stocktwits
Ac-PSMA: The Truth Should be Told! "Presentation" - Matthias Eiber - UroToday
Phase 1 Trial of an Actinium-Labeled KLK2-Targeting Antibody for mCRPC - Michael Morris - UroToday
Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates – Company Announcement - FT.com - Financial Times
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research - BioSpace
TerraPower Isotopes announces cGMP manufacturing facility - PR Newswire
TerraPower Isotopes Breaks Ground on World's Largest Actinium-225 Manufacturing Facility in Philadelphia - PR Newswire
Actinium Pharmaceuticals Oral Presentation at SNMMI 2026 Highlights ATNM-400 Overcoming Resistance to All Three Approved Androgen Receptor Inhibitors and Offers Flexible, Well-Tolerated Dosing in Prostate Cancer Models - The Malaysian Reserve
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com South Africa
Actinium optimizes chelator-to-antibody ratio to enhance cancer drug targeting and safety - Pluang
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs - Barchart
Niowave Invests $75 Million in Actinium-225 Production Plant Following Deals with AstraZeneca and Novartis - geneonline.com
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficac - PR Newswire
TerraPower Isotopes plans Philadelphia facility to expand actinium-225 supply - DOTmed
Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan
Actinium Pharmaceuticals (NYSE: ATNM) CFO resigns; CEO adds finance role - Stock Titan
Niowave to supply actinium-225 to Novartis under long-term agreement - DOTmed
TerraPower to build actinium-225 manufacturing site in Pennsylvania - megaproject.com
SNMMI 2025: How About Actinium-225? - UroToday
First Patient With Breast Cancer Dosed With Novel Radioactive Medicine - Cure Today
TerraPower Isotopes Breaks Ground on Major Actinium-225 Facility in Philadelphia - citybiz
Actinium presents preclinical data on AML drug at AACR meeting - Investing.com
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com UK
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com Australia
Cardinal Health expands Ac-225 production - AuntMinnie
Actinium presents radiochemistry data on antibody ratio optimization By Investing.com - Investing.com Australia
Actinium to present preclinical data at AACR meeting April 21 - Investing.com
Preclinical data show promise of ATNM-400 for prostate cancer - Urology Times
New radioactive isotope therapies promise more targeted attacks on cancer - Science | AAAS
SK Biopharm secures Actinium-225 supply in Europe with Eckert & Ziegler deal - The Korea Herald
Actinium presents preclinical data on ATNM-400 for lung cancer By Investing.com - Investing.com Canada
NorthStar Medical Radioisotopes Confirms Successful Routine Commercial-scale Ac-225 Production - Business Wire
Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study - The Economic Times
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies - Investing News Network
Company mines Oak Ridge National Lab's nuclear waste for nuclear medicine - Oakridger
Actinium Highlights Expanded Data Set for ATNM-400 in Prostate Cancer Demonstrating Superior Efficacy to Enzalutamide and Ability to Overcome Resistance to ARPI Therapy and PSMA-Ac-225/Lu-177 Labelled Radiotherapy at the Society of Nuclear Medic - PR Newswire
TerraPower Isotopes to build Ac-225 facility in Philadelphia - AuntMinnie
PanTera breaks ground on Ac-225 facility - Nuclear Engineering International
Surge in Radiopharmaceutical R&D Puts Pressure on Unique Supply Chain - BioSpace
Bill Gates-backed company breaks ground on 'world's most advanced' isotope production facility - Radiology Business
TerraPower starts work on flagship actinium-225 facility in Philadelphia - energynews.pro
Mayo Clinic delivers first US treatment using actinium-based radiotherapy for breast cancer - DOTmed
Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics - PR Newswire
Actinium Pharmaceuticals Provides Business Update After Presentation at Trump Mar-A-Lago Club Announcing Novel Non-PSMA Prostate Cancer Radiotherapy ATNM-400 and Outlining Revitalized Clinical Pipeline with 2025 Corporate Objectives - PR Newswire
Foreign Language Equivalents
Foreign Language Equivalents of 'actinium'
Language Equivalent   Language Equivalent
French actinium    Spanish
Misspellings - Typos
ctinium,   actiium,   actonium,   actiniu,,   actinoum,   catinium,   actinnium,   actiniym,   actnium,   actiniumm,   actiniim,   avtinium,   acyinium,   actiniium,   actinuim,   actinuum,   sctinium,   actibium,   atinium,   actunium,   acttinium,   actinum,   actiniu,   acctinium,   actniium,   atcinium,   actiinum,   actinimu,   acrinium,   acitnium,   acinium,   actimium,   actinim,   actiniun,   actiinium,   aactinium,   axtinium,   actiniuum
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z